307 related articles for article (PubMed ID: 28650247)
1. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
[TBL] [Abstract][Full Text] [Related]
2. The Economic Burden of Opioid Abuse: Updated Findings.
Kirson NY; Scarpati LM; Enloe CJ; Dincer AP; Birnbaum HG; Mayne TJ
J Manag Care Spec Pharm; 2017 Apr; 23(4):427-445. PubMed ID: 28345440
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
[TBL] [Abstract][Full Text] [Related]
4. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
[TBL] [Abstract][Full Text] [Related]
5. Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use.
Coutinho AD; Gandhi K; Fuldeore RM; Landsman-Blumberg PB; Gandhi S
J Opioid Manag; 2018; 14(2):131-141. PubMed ID: 29733099
[TBL] [Abstract][Full Text] [Related]
6. Opioid Abuse: A Detailed Examination of Cost Drivers over a 24-Month Follow-up Period.
Scarpati LM; Kirson NY; Jia ZB; Wen J; Howard J
J Manag Care Spec Pharm; 2017 Nov; 23(11):1110-1115. PubMed ID: 29083966
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
Roland CL; Ye X; Stevens V; Oderda GM
J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
[TBL] [Abstract][Full Text] [Related]
8. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
Wei W; Gandhi K; Blauer-Peterson C; Johnson J
J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
[TBL] [Abstract][Full Text] [Related]
9. Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study.
Chen C; Winterstein AG; Lo-Ciganic WH; Tighe PJ; Wei YJ
PLoS Med; 2022 Mar; 19(3):e1003921. PubMed ID: 35231025
[TBL] [Abstract][Full Text] [Related]
10. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients.
Brummett CM; Evans-Shields J; England C; Kong AM; Lew CR; Henriques C; Zimmerman NM; Sun EC
J Manag Care Spec Pharm; 2021 Jun; 27(6):760-771. PubMed ID: 33624534
[No Abstract] [Full Text] [Related]
11. Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies.
Schwedt TJ; Lee J; Knievel K; McVige J; Wang W; Wu Z; Gillard P; Shah D; Blumenfeld AM
J Manag Care Spec Pharm; 2023 Oct; 29(10):1119-1128. PubMed ID: 37776119
[No Abstract] [Full Text] [Related]
12. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
John WS; Wu LT
Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Direct Health Care Costs Among Patients with Migraine.
Bonafede M; Cai Q; Cappell K; Kim G; Sapra SJ; Shah N; Widnell K; Winner P; Desai P
J Manag Care Spec Pharm; 2017 Nov; 23(11):1169-1176. PubMed ID: 29083975
[TBL] [Abstract][Full Text] [Related]
14. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
[TBL] [Abstract][Full Text] [Related]
15. Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study.
Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L
BMC Pharmacol Toxicol; 2014 Mar; 15():17. PubMed ID: 24646721
[TBL] [Abstract][Full Text] [Related]
16. Direct Costs of Opioid Abuse in an Insured Population in the United States.
White AG; Birnbaum HG; Mareva MN; Daher M; Vallow S; Schein J; Katz N
J Manag Care Spec Pharm; 2020 Oct; 26(10):1188-1198. PubMed ID: 32996392
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain.
Ivanova JI; Birnbaum HG; Yushkina Y; Sorg RA; Reed J; Merchant S
J Opioid Manag; 2013; 9(4):239-54. PubMed ID: 24353017
[TBL] [Abstract][Full Text] [Related]
18. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
[TBL] [Abstract][Full Text] [Related]
19. Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients.
Landsman-Blumberg PB; Katz N; Gajria K; D'Souza AO; Chaudhari SL; Yeung PP; White R
J Pain Res; 2017; 10():1713-1722. PubMed ID: 28769587
[TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.
Gudin J; Fudin J; Wang E; Haylon T; Patel K; Goss TF
J Manag Care Spec Pharm; 2019 Dec; 25(12):1387-1396. PubMed ID: 31589557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
